2019-05-15 New data for larotrectinib show overall response rates of 94% in children and 76% in adults with TRK fusion cancer; clinical benefit demonstrated in patients with primary central nervous system tumors and brain metastases
2019-05-13 Bayer to present new data at ASCO 2019 highlighting commitment to evolve cancer treatment paradigm
2019-04-29 Study reaffirms safety and efficacy profile of Xarelto™ for the prevention of stroke in patients with atrial fibrillation
